This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cutting-edge approaches to trial and study design, technology, sourcing, data disclosure and medical communications.

Clinical Trials during COVID-19 | Clinical Trials eBook Series

Share this article

With much of the world at various levels of lockdown for most of 2020, face to face interaction has been hugely restricted for clinical trials. For many, this has meant either the postponement of studies, or a rapid adoption of decentralized or hybrid trials. At the same time, clinical trials have taken on huge importance in the development of both treatment and a vaccine for COVID-19, moving through phases faster than ever before. In this edition of the Clinical Trials eBook Series, we take an in-depth look at the impact that COVID-19 has had on clinical trials.

Click on the image above or here, to read the interactive report, or jump straight to any of the articles:

Share this article

Upcoming event

Clinical Trials Europe

02 - 04 Nov 2021, Delivered in GMT time zone
Europe’s largest event dedicated to streamlining clinical trials and improving the lives of patients
Go to site